Zobrazeno 1 - 10
of 49 432
pro vyhledávání: '"Real-world"'
Autor:
Glodek, Geraldine
Publikováno v:
Pennsylvania Literary Journal (2151-3066). Spring2023, Vol. 15 Issue 1, p164-171. 8p.
Autor:
Amelia Hochreiter-Hufford, Jennifer Gatz, Amy M. Griggs, Ryan D. Schoch, Kimberly M. Birmingham, Christopher Frederick, John Price, Scott Snyder
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Recognizing the limitations of pre-market clinical data, regulatory authorities have embraced total product lifecycle management with post-market surveillance (PMS) data to assess medical device safety and performance. One method
Externí odkaz:
https://doaj.org/article/11207303ddb04602a63f0a7731328d79
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Evaluating outcome reliability is critical in real-world evidence studies. Overall survival is a common outcome in these studies; however, its capture in real-world data (RWD) sources is often incomplete and supplemented with link
Externí odkaz:
https://doaj.org/article/3abdb24e56ae4579a2ae542b464c222e
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 395-418 (2024)
Abstract Introduction Limited awareness exists regarding real-world data (RWD) for palbociclib in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced/metastatic breast cancer in populations from certain
Externí odkaz:
https://doaj.org/article/d3d5c5d38dd54e5fb401805a467c3fba
Publikováno v:
International Journal of Sustainability in Higher Education, 2024, Vol. 25, Issue 6, pp. 1297-1314.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJSHE-01-2023-0011
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 11, Iss 4, Pp 423-427 (2024)
Objective: To determine the efficacy and safety of the Yinmei Kuijie decoction combined with 5-aminosalicylic acid (5-ASA) in treating mildly to moderately active ulcerative colitis (UC) under real-world conditions. Methods: This multicenter, prospec
Externí odkaz:
https://doaj.org/article/ebc6bbeed26f4eeca9a27ea6a6e4c90a
Autor:
Benson VS, Siddall J, Haq A, Small M, Tang Z, Ye T, Howarth P, Richards A, Alfonso-Cristancho R
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 1041-1054 (2024)
Victoria S Benson,1,* James Siddall,2,* Adam Haq,2 Mark Small,2 Zhiliu Tang,3 Tao Ye,4 Peter Howarth,5 Anna Richards,6 Rafael Alfonso-Cristancho7 1Epidemiology, Value Evidence & Outcomes, GSK, London, UK; 2Adelphi Real World, Bollington, UK;
Externí odkaz:
https://doaj.org/article/20e223d195f64364a356c2048d443ea9
Psychometric evaluation of the Adelphi Adherence Questionnaire (ADAQ©) in adults with osteoarthritis
Autor:
Nathan Clarke, Andrew Trigg, Rob Arbuckle, Jan Stochl, Victoria Higgins, Sarah Bentley, James Piercy
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background Medication non-adherence is a common issue in chronic illness. The World Health Organization has recognized a need for a valid and reliable method of measuring adherence to understand and mitigate non-adherence. This study aimed t
Externí odkaz:
https://doaj.org/article/1e377249adda452f8ab8ae9896b1474c
Autor:
Sudha R. Raman, Bradley G. Hammill, Pamela A. Shaw, Hana Lee, Sengwee Toh, John G. Connolly, Kimberly J. Dandreo, Vinit Nalawade, Fang Tian, Wei Liu, Jie Li, José J. Hernández-Muñoz, Robert J. Glynn, Rishi J. Desai, Janick Weberpals
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Missing data in confounding variables present a frequent challenge in generating evidence using real-world data, including electronic health records (EHR). Our objective was to apply a recently published toolkit for characterizing
Externí odkaz:
https://doaj.org/article/4ae0b29ad6134def83c0064c37302018
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-8 (2024)
Abstract Objective This study used real-world observational data to compare profiles of patients receiving different first-line treatment for hormone receptor positive (ER+), HER2 negative, metastatic breast cancer (MBC): CDK4/6 inhibitors (CDK4/6i)
Externí odkaz:
https://doaj.org/article/85c8f2c797de414faac06f0916ec2555